Emerging Science

Researchers used electrostatic co-assembly to package PDRN with poly(L-lysine) into nanospheres averaging approximately 138 nanometers, with reported loading efficiency of 93.3%. Compared with free PDRN, the particles improved skin retention, penetration and hydration-related performance in the reported experimental systems.

The work provides a concrete carrier strategy for a large, highly charged nucleic-acid material. Important limitations include a relatively broad particle-size distribution, incomplete clarity about how well the penetration model represents intact human facial skin and no finished-product human clinical study.

In three women, researchers used tape stripping and OrbiSIMS chemical imaging to map palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7 after topical application. Both Matrixyl 3000 peptides were identified throughout the sampled stratum corneum and appeared to follow lipid-rich intercellular pathways.

Longer exposure from 30 minutes to five hours did not produce a clear increase in depth. The study is valuable because it identifies the intact peptide signals in human skin, but it sampled only the stratum corneum in three young, light-skinned participants and did not demonstrate delivery into viable epidermis or dermis.

This study maintained native human skin for four weeks while preserving tissue architecture and epidermal, stromal and immune-associated molecular programs. Across 199 samples from 20 donors, the platform modeled prolonged IL-17 and IL-22 inflammation, UVB stress and age-related responses using RNA sequencing, histology and secreted biomarkers.

Some intervention effects, including changes in IL-6 and MMP-1, became apparent at week three but not week one. The model enables longer and more biologically relevant testing than short skin-explant assays, although it remains ex vivo, lacks systemic circulation and was developed by authors employed by or holding equity in the platform company.

This review describes cellular senescence as heterogeneous, time-dependent and context-specific. Transient senescence and its secretory signals can contribute to orderly repair, while persistent senescent-cell accumulation and chronic SASP signaling can impair tissue integrity and regenerative capacity.

The authors emphasize that cell subtype, tissue condition, timing and therapeutic specificity all matter. The evidence base is rigorous but remains dominated by mechanistic, animal and wound-healing research; it does not validate a cosmetic senomorphic ingredient or a finished topical formula.

This review connects single-cell and spatial aging atlases with mRNA strategies intended to restore proteins that decline with age. It also makes the central delivery constraint explicit: naked mRNA is rapidly degraded, has poor cellular uptake and does not readily cross intact stratum corneum.

The successful approaches surveyed rely on lipid nanoparticles, extracellular vesicles, microneedles or combined delivery systems. The paper is a rigorous translational review, not a human trial of a topical cosmetic, and much of the supporting evidence comes from carrier-mediated or intradermal preclinical studies.

This review separates matrikines, copper-binding peptides, neuromodulatory peptides, pigment-modulating peptides, collagen hydrolysates and growth factors rather than treating them as one interchangeable class. It concludes that activity depends on exact sequence, chemical modification, dose, vehicle, route and comparator.

The authors also note that lipidation and encapsulation can change exposure, and that carrier activity must be separated from payload activity. The review is useful but not systematic; much of the clinical literature involves small samples, short studies, combination formulas and industry sponsorship.

Researchers applied AI-assisted reflectance confocal microscopy to images from a prior randomized, double-blind split-face study. In the 25 participants from the 2.5% treatment arm, 56 days of topical use shifted several stratum-granulosum features, including keratinocyte density, cellular circularity and intercellular spacing, toward patterns interpreted as more normal.

The findings were exploratory. The measured features are associated with age and senescence but do not directly identify senescent cells; several nominally significant results did not remain significant after correction for multiple comparisons. The study was also manufacturer funded, with most contributors employed by the company.

This review brings together evidence that skin structure, immune behavior and microbial ecology vary materially by body site. Stratum-corneum thickness can differ by roughly 10- to 100-fold, while follicle density, sebaceous and sweat-gland activity, resident immune populations and microbial communities also change by location.

The paper explains why inflammation can present and respond differently across regions. It is a mechanistic expert review rather than a trial of a cosmetic ingredient or finished product, so it strengthens study design and interpretation rather than proving product efficacy.

Fifty-two adults completed a randomized 10-day cleansing study comparing cool and warm water. Repeated warm-water cleansing increased transepidermal water loss by approximately 3.4 g/m²/h, while the smaller change with cool water was not statistically significant. Cool water also reduced surface pH by 0.4 units, and makeup-removal performance did not differ between temperatures.

Trout-derived polynucleotides reduced activation of NF-κB, MAPK and JAK1/STAT3 pathways in stimulated keratinocytes and macrophages. Treatment also lowered multiple inflammatory cytokines and chemokines, including IL-6, IL-1β, TSLP, CCL17 and CCL22. Functional testing used concentrations of 100 to 500 micrograms per milliliter.

In an 83-patient retrospective series involving grade II or III chemotherapy-related hand-foot syndrome, 80.7% of patients improved by at least one severity grade after three weeks of topical recombinant human EGF gel plus urea ointment. Median time to documented improvement was 10 days, and no serious treatment-related adverse events were reported.

Researchers evaluated a medium-length PDRN preparation with an average molecular weight no greater than 850 kDa across fibroblast signaling, reconstructed epidermis, porcine skin, UV-damaged human skin and a 31-person randomized split-face clinical study. At 0.1%, PDRN-associated signals appeared in viable epidermal regions, while the clinical formula improved measured periocular wrinkles, dermal thickness, density and firmness over 28 days.

The study connected these results to PI3K-Akt, TGF-β/Smad and autophagy-related signaling. Important limitations include a one-person in-vivo penetration pilot, the inability of Raman spectroscopy to identify applied PDRN with complete certainty and a clinical period too short to separate mature remodeling from hydration-related effects.

This study used mild vacuum to move PDRN through silica-particle media, reducing its radius of gyration from 52.92 to 29.36 nanometers without detectable fragmentation or loss of biological activity. The compacted material showed improved cellular uptake, procollagen production, penetration and wound-repair activity while preserving adenosine A2A receptor signaling.

A non-covalent carrier assembled from α-bisabolol and dipalmitoyl hydroxyproline increased viable-epidermal deposition of a roughly 5 kDa recombinant collagen peptide by 22.43-fold compared with the free peptide. The reported penetration depth reached approximately 40 micrometers after eight hours. The system also affected filaggrin, loricrin, inflammatory markers and multiple collagen types.